Novartis

Novartis is a global healthcare company headquartered in Switzerland, dedicated to addressing evolving patient needs worldwide. It operates through several divisions: Novartis Pharmaceuticals for innovative medicines, Sandoz for generics and biosimilars, and Alcon for eye care devices. The company focuses on key therapeutic areas such as oncology, rare diseases, neuroscience, immunology, respiratory, and cardio-metabolic diseases. Novartis also invests in early-stage life sciences and biotechnology companies through its venture capital arm, Novartis Venture Fund, seeking innovative therapeutics, medical devices, diagnostics, and drug delivery systems. Additionally, Novartis Animal Health develops products for pets, farm animals, and farmed fish, contributing to animal health and welfare. The company's research and development efforts are supported by the Genomics Institute of the Novartis Research Foundation, which bridges basic science and preclinical drug discovery.

Elena Battistello Ph.D

Analyst

Laura Brass

Managing Director

Adam Cotton Ph.D

Associate

Mathias Frederiksen

Principal

Sharon Kiernan

Director of Strategic Planning and Business Operations, Office of Chief Technology Transformation Officer

Michelle Ma Ph.D

Analyst

Nadene McIntyre

Associate Director Access and Reimbursement

Campbell Murray

Managing Director

Marion Mutter

Senior Clinical Research Associate

Aaron Nelson

Managing Director

Pascal Qian

Executive Director ( Head of Solid Tumor)

Michal Silverberg

Managing Director

Lauren Silverman

Managing Director

Beat Steffen

Managing Director

Marianne Uteng Ph.D

Managing Director

Alberto Villena

Director, M&A, Finance

Maurizio Voi

Vice President, Global Program Head, Tislelizumab, Immuno Oncology

Steve Weinstein

Managing Director

Past deals in Macau

SanReno Therapeutics

Acquisition in 2024
SanReno Therapeutics specializes in the development, manufacturing, and commercialization of therapies for kidney diseases in several regions including the People's Republic of China, Hong Kong, Macau, Taiwan, and Singapore. Established through a joint venture involving Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, the company is dedicated to researching and producing innovative biotech solutions aimed at improving the quality of life for patients suffering from kidney-related conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.